Piermont Capital Management Inc. - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 131 filers reported holding CYTOKINETICS INC in Q3 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q1 2018$119,000
-23.7%
16,530
-13.6%
0.04%
-21.6%
Q4 2017$156,000
-46.8%
19,130
-5.3%
0.05%
-47.4%
Q3 2017$293,000
-40.1%
20,200
-50.0%
0.10%
-30.7%
Q2 2017$489,000
-20.1%
40,418
-15.1%
0.14%
-4.1%
Q1 2017$612,00047,6180.15%
Other shareholders
CYTOKINETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,723,170$13,940,0005.01%
RP Management, LLC 875,656$7,084,0003.54%
BVF INC/IL 3,801,817$30,757,0003.44%
DAFNA Capital Management LLC 400,294$3,238,0001.40%
Virtus ETF Advisers LLC 33,758$273,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 67,352$545,0000.44%
WASATCH ADVISORS LP 3,188,487$25,795,0000.28%
LANSDOWNE PARTNERS (UK) LLP 1,459,706$11,809,0000.26%
Campbell & CO Investment Adviser LLC 43,844$355,0000.18%
Fosun International Ltd 239,792$1,981,0000.13%
View complete list of CYTOKINETICS INC shareholders